Brief: Abivax Announces Pricing Of $650 Mln Public Offering Of American Depositary Shares
July 24 (Reuters) - Abivax SA ABVX.PA: EQS-NEWS: ABIVAX ANNOUNCES PRICING OF $650M (€554M) PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES OFFERING EXPECTED TO CLOSE ON JULY 28, 2025 OFFERS 10,156,000 ADSS EUR 0.01 NOMINAL VALUE PER SHARE, IN UNITED STATES AT AN OFFERING PRICE OF $64.00 PER ADS ORDINARY SHARES TO TRADE ON EURONEXT JULY 28, 2025 Source text: ID:nEQ61pZsFa Further company coverage: ABVX.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data